2023
DOI: 10.1016/j.jdbs.2023.05.003
|View full text |Cite
|
Sign up to set email alerts
|

Employing LFP recording to optimize stimulation location and amplitude in chronic DBS for Parkinson’s disease: A proof-of-concept pilot study

Bart E.K.S. Swinnen,
Mariëlle J. Stam,
Arthur W.G. Buijink
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 25 publications
0
2
0
Order By: Relevance
“…Evidence is building that BrainSense may be used to guide DBS programming setup and optimization in movements disorders and epilepsy (Feldmann et al, 2021 ; Buijink et al, 2022 ; Fasano et al, 2022 ; Strelow et al, 2022 ; Chua et al, 2023 ; Swinnen et al, 2023 ). Recent studies in Parkinson's disease suggest BrainSense can be used to streamline and reduce the time for initial DBS programming (Binder et al, 2023 ; Lewis et al, 2023 ), troubleshoot difficult cases, identify medication interactions, and mitigate potential overstimulation (Kern et al, 2022 ; Vaou et al, 2023 ).…”
Section: Advances In Commercially Available Neuromodulation Technologiesmentioning
confidence: 99%
“…Evidence is building that BrainSense may be used to guide DBS programming setup and optimization in movements disorders and epilepsy (Feldmann et al, 2021 ; Buijink et al, 2022 ; Fasano et al, 2022 ; Strelow et al, 2022 ; Chua et al, 2023 ; Swinnen et al, 2023 ). Recent studies in Parkinson's disease suggest BrainSense can be used to streamline and reduce the time for initial DBS programming (Binder et al, 2023 ; Lewis et al, 2023 ), troubleshoot difficult cases, identify medication interactions, and mitigate potential overstimulation (Kern et al, 2022 ; Vaou et al, 2023 ).…”
Section: Advances In Commercially Available Neuromodulation Technologiesmentioning
confidence: 99%
“…Right lead Our study is the first to suggest that LFPs could potentially be used to guide contact selection in patients with OCD. In Parkinson's disease, beta band LFPs have been used to guide contact selection (1,5,8,10). One study showed that when contacts were selected using LFP signals in the beta band, the clinical efficacy of DBS did not differ from when they were selected using traditional monopolar and bipolar review conducted by highly specialized clinicians (6).…”
Section: Left Leadmentioning
confidence: 99%